AJOG: Adverse Pregnancy Outcomes and Predicted 30-Year Risk of Maternal Cardiovascular Disease 2–7 Years After Delivery

OBJECTIVE:  To determine whether adverse pregnancy outcomes are associated with a higher predicted 30-year risk of atherosclerotic cardiovascular disease (CVD; ie, coronary artery disease or stroke). METHODS:  This was a…

Read More from AJOG: Adverse Pregnancy Outcomes and Predicted 30-Year Risk of Maternal Cardiovascular Disease 2–7 Years After Delivery

AJOG: Low-Dose aspirin use in pregnancy and risk or preterm birth: a Swedish register-based cohort study

AJOG: Low-Dose aspirin use in pregnancy and risk or preterm birth: a Swedish register-based cohort study Background Preterm birth is the leading cause of neonatal mortality and morbidity. Women who…

Read More from AJOG: Low-Dose aspirin use in pregnancy and risk or preterm birth: a Swedish register-based cohort study

AJOG: Preterm labor is a distinct process from term labor following computational analysis of human myometrium

ABSTRACT Background The onset of the term human parturition involves myometrial gene expression changes to transform the uterus from a quiescent to a contractile phenotype. It is uncertain whether the…

Read More from AJOG: Preterm labor is a distinct process from term labor following computational analysis of human myometrium

AJOG: Trajectories of antenatal depression and adverse pregnancy outcomes

ABSTRACT Background Antenatal depression affects approximately 1 of 7 pregnancies, with an increasing prevalence across gestation. Data regarding the associations between antenatal depression and adverse pregnancy outcomes yielded conflicting results….

Read More from AJOG: Trajectories of antenatal depression and adverse pregnancy outcomes

SMFM Statement: The Choice of Progestogen for the Prevention of Preterm Birth in Women with Singleton Pregnancy and Prior Preterm Birth

The Society for Maternal-Fetal Medicine (SMFM) has released a statement addressing the use of 17-alpha hydroxyprogesterone caproate (17-OHPC) therapy to prevent preterm birth (PTB) out of concern that women who…

Read More from SMFM Statement: The Choice of Progestogen for the Prevention of Preterm Birth in Women with Singleton Pregnancy and Prior Preterm Birth

Press Release: Oklahoma Earns March of Dimes Virginia Apgar Award for Prematurity Campaign

For Release: January 17, 2017 Oklahoma Earns March of Dimes Virginia Apgar Award for Prematurity Campaign Oklahoma lowered its preterm birth rate by at least 8 percent since 2010, giving more…

Read More from Press Release: Oklahoma Earns March of Dimes Virginia Apgar Award for Prematurity Campaign

Free Online CME: Role of Fetal Fibronectin in Identifying the Risk of Preterm Labor

TARGET AUDIENCE The target audience for this activity includes ob/gyns, maternal fetal medicine specialists, obstetric hospitalists, CNMs, labor and delivery nursing staff, and women’s health residents. Click here for the…

Read More from Free Online CME: Role of Fetal Fibronectin in Identifying the Risk of Preterm Labor